Andlauer Healthcare Group Inc
TSX:AND
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
37.1
44.92
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Andlauer Healthcare Group Inc
Cost of Revenue
Andlauer Healthcare Group Inc
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Andlauer Healthcare Group Inc
TSX:AND
|
Cost of Revenue
-CA$328.5m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Medivolve Inc
OTC:MEDVF
|
Cost of Revenue
-CA$111.1k
|
CAGR 3-Years
74%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
WELL Health Technologies Corp
TSX:WELL
|
Cost of Revenue
-CA$403.8m
|
CAGR 3-Years
-141%
|
CAGR 5-Years
-123%
|
CAGR 10-Years
N/A
|
|
|
dentalcorp Holdings Ltd
TSX:DNTL
|
Cost of Revenue
-CA$728.9m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
KDA Group Inc
XTSX:KDA
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
H
|
Healwell Al Inc
TSX:AIDX
|
Cost of Revenue
-CA$6.1m
|
CAGR 3-Years
38%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
Andlauer Healthcare Group Inc
Glance View
Andlauer Healthcare Group, Inc. is a supply chain management company with a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector. The company is headquartered in Vaughan, Ontario. The company went IPO on 2019-12-11. The firm provides a platform of customized third-party logistics (3PL) and transportation solutions for the healthcare sector. The firm operates through two segments: Specialized Transportation and Healthcare Logistics. Its Specialized Transportation segment involves provision of specialized temperature-controlled, as well as non-temperature controlled, ground transportation, air freight forwarding and dedicated and last mile transportation product lines, which are offered under its ATS Healthcare, ATS Dedicated and Skelton brands. The Company’s Healthcare Logistics segment provides supply chain services for its customers, including logistics and distribution services and packaging solutions. Its 3PL services are provided under its Accuristix brand. The company offers services to healthcare manufacturers, wholesalers, distributors and 3PL providers.
See Also
What is Andlauer Healthcare Group Inc's Cost of Revenue?
Cost of Revenue
-328.5m
CAD
Based on the financial report for Dec 31, 2023, Andlauer Healthcare Group Inc's Cost of Revenue amounts to -328.5m CAD.
What is Andlauer Healthcare Group Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-23%
Over the last year, the Cost of Revenue growth was -2%. The average annual Cost of Revenue growth rates for Andlauer Healthcare Group Inc have been -36% over the past three years , -23% over the past five years .
You don't have any saved screeners yet
